Disclosed is a cell-binding agent-cytotoxic agent conjugate represented by the following structural formula as disclosed in the abstract drawing, wherein the different embodiments of the conjugate are as disclosed in the specification. Further disclosed is the use of said conjugate in the manufacture of a medicament for the treatment of cancer.